Reactogenicity to the mRNA-1273 Booster According to Previous mRNA COVID-19 Vaccination

The objective of this study was to assess the local and systemic adverse reactions after the administration of a COVID-19 mRNA-1273 booster between December 2021 and February 2022 by comparing the type of mRNA vaccine used as primary series (mRNA-1273 or BNT162b2) and homologous versus heterologous...

Descripción completa

Detalles Bibliográficos
Autores principales: Parés-Badell, Oleguer, Zules-Oña, Ricardo, Armadans, Lluís, Pinós, Laia, Borrás-Bermejo, Blanca, Otero, Susana, Rodrigo-Pendás, José Ángel, Vivet-Escalé, Martí, Cossio-Gil, Yolima, Agustí, Antònia, Aguilera, Cristina, Campins, Magda, Martínez-Gómez, Xavier
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414494/
https://www.ncbi.nlm.nih.gov/pubmed/36016105
http://dx.doi.org/10.3390/vaccines10081217

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414494/
https://www.ncbi.nlm.nih.gov/pubmed/36016105
http://dx.doi.org/10.3390/vaccines10081217

Ejemplares similares